Gilead Sciences to Release Fourth Quarter and Full Year 2019 Financial Results on Tuesday, February 4, 2020
January 21 2020 - 05:30PM
Business Wire
-- Conference Call and Webcast to Follow
--
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its
fourth quarter and full year 2019 financial results will be
released on Tuesday, February 4, after the market closes. At 4:30
p.m. Eastern Time, Gilead’s management will host a conference call
to discuss the company’s fourth quarter and full year 2019
financial results and will provide a business update.
The live webcast of the call can be accessed at the company’s
Investors page at http://investors.gilead.com. Please connect to
the company’s website at least 15 minutes prior to the start of the
call to ensure adequate time for any software download that may be
required to listen to the webcast. Alternatively, please call
877-359-9508 (U.S.) or 224-357-2393 (international) and dial the
conference ID 9634129 to access the call. Telephone replay will be
available approximately two hours after the call through 8:00 p.m.
Eastern Time, February 6, 2020. To access the replay, please call
855-859-2056 (U.S.) or 404-537-3406 (international) and dial the
conference ID 9634129. The webcast will be archived on
www.gilead.com for one year.
About Gilead
Gilead Sciences, Inc. is a research-based biopharmaceutical
company that discovers, develops and commercializes innovative
medicines in areas of unmet medical need. The company strives to
transform and simplify care for people with life-threatening
illnesses around the world. Gilead has operations in more than 35
countries worldwide, with headquarters in Foster City,
California.
For more information on Gilead Sciences, please
visit the company’s website at www.gilead.com, follow Gilead on
Twitter (@GileadSciences) or call Gilead Public Affairs at
1-800-GILEAD-5 or 1-650-574-3000.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200121006118/en/
Douglas Maffei, Ph.D. Investor Relations (650) 522-2739
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Feb 2024 to Mar 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Mar 2023 to Mar 2024